NIAGEN BIOSCIENCE, INC. Contractual Obligation, to be Paid, after Year Five
NIAGEN BIOSCIENCE, INC. (NAGE) had Contractual Obligation, to be Paid, after Year Five of GBP 245.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Notes › Commitment and Contingencies › Contractual Obligation, Fiscal Year Maturity
us-gaap:ContractualObligationDueAfterFifthYear · last filed 2026-03-04
- 2025-12-31: Contractual Obligation, to be Paid, after Year Five 245.00K GBP.
GBP
| Period end | Contractual Obligation, to be Paid, after Year Five |
|---|---|
| 2025-12-31 | 245.00K GBP 10-K · filed 2026-03-04 |
USD
| Period end | Contractual Obligation, to be Paid, after Year Five |
|---|---|
| 2025-12-31 | $7.00M 10-K · filed 2026-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |